Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 6, 2015, Pages 3413-3423

  Curiao, Tânia ^a,c   Marchi, Emmanuela ^d   Viti, Carlo ^d   Oggioni, Marco R ^e   Baquero, Fernando ^a,b,c   Martinez, José Luis ^b,f   Coque, Teresa M ^a,b,c  

^a INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

^b CSIC   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMPICILLIN; ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; BIOCIDE; CARBOHYDRATE; CARBOXYLIC ACID; CEFTAZIDIME; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; HYPOCHLORITE SODIUM; TETRACYCLINE; TRICLOSAN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BENZALKONIUM; DISINFECTANT AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM MUTANT; DRUG EXPOSURE; DRUG METABOLISM; ESCHERICHIA COLI; GENE EXPRESSION; GENE SEQUENCE; GROWTH RATE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OBSERVATIONAL STUDY; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; DRUG EFFECTS; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BENZALKONIUM COMPOUNDS; CHLORHEXIDINE; DISINFECTANTS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; SODIUM HYPOCHLORITE; TRICLOSAN;

EID: 84929648665     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00187-15     Document Type: Article

References (60)

1. McDonnell G, Russell AD. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147-179.
2. Whitehead RN, Overton TW, Kemp CL, Webber MA. 2011. Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step. PLoS One 6:e22833. http://dx.doi.org/10.1371/journal.pone.0022833.
3. Randall LP, Cooles SW, Coldham NG, Penuela EG, Mott AC, Woodward MJ, Piddock LJV, Webber MA. 2007. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence. J Antimicrob Chemother 60:1273-1280. http://dx.doi.org/10.1093/jac/dkm359.
4. Karatzas KAG, Webber MA, Jorgensen F, Woodward MJ, Piddock LJV, Humphrey TJ. 2007. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 60:947-955. http://dx.doi.org/10.1093/jac/dkm314.
5. Cheung H, Wong MM, Cheung S, Liang LY, Lam Y, Chiu S. 2012. Differential actions of chlorhexidine on the cell wall of Bacillus subtilis and Escherichia coli. PLoS One 7:e36659. http://dx.doi.org/10.1371/journal.pone.0036659.
6. Piddock LJV. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19:382-402. http://dx.doi.org/10.1128/CMR.19.2.382-402.2006.
7. Bailey AM, Ivens A, Kingsley R, Cottell JL, Wain J, Piddock LJV. 2010. RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium. J Bacteriol 192:1607-1616. http://dx.doi.org/10.1128/JB.01517-09.
8. Webber MA, Bailey AM, Blair JMA, Morgan E, Stevens MP, Hinton JCD, Ivens A, Wain J, Piddock LJV. 2009. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 191:4276-4285. http://dx.doi.org/10.1128/JB.00363-09.
9. Heath RJ, Rubin JR, Holland DR, Zhang E, Snow ME, Rock CO. 1999. Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem 274:11110-11114. http://dx.doi.org/10.1074/jbc.274.16.11110.
10. Heath RJ, Yu YT, Shapiro MA, Olson E, Rock CO. 1998. Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem 273:30316-30320. http://dx.doi.org/10.1074/jbc.273.46.30316.
11. Pérez A, Poza M, Fernández A, Fernández Mdel C, Mallo S, Merino M, Rumbo-Feal S, Cabral MP, Bou G. 2012. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 56:2084-2090. http://dx.doi.org/10.1128/AAC.05509-11.
12. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2009. Assessment of the antibiotic resistance effects of biocides. European Commission, Directorate-General for Health & Consumers, Brussels, Belgium. http://ec.europa.eu/health/ph-risk/committees/04-scenihr/docs/scenihr-o-021.pdf.
13. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). 2010. Research strategy to address the knowledge gaps on the antimicrobial resistance effects of biocides. European Commission, Directorate-General for Health & Consumers, Brussels, Belgium. http://ec.europa.eu/health/scientific-committees/emerging/docs/scenihr-o-028.pdf.
14. Parliamentary Office of Science & Technology. 2013. Antibiotic resistance in the environment, POST Note no. 446. Parliamentary Office of Science & Technology, Houses of Parliament, London, United Kingdom. http://www.parliament.uk/business/publications/research/briefing-papers/POST-PN-446/antibiotic-resistance-in-the-environment.
15. Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S. 2012. Reduced susceptibility to chlorhexidine among extremely-drugresistant strains of Klebsiella pneumoniae. J Hosp Infect 81:15-19. http://dx.doi.org/10.1016/j.jhin.2012.02.007.
16. Alvarez-Ortega C, Olivares J, Martínez JL. 2013. RND multidrug efflux pumps: what are they good for? Front Microbiol 4:7. http://dx.doi.org/10.3389/fmicb.2013.00007.
17. Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne J-P, Bert F, Moreau R, Nicolas-Chanoine M-H. 2011. In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother 55: 2795-2802. http://dx.doi.org/10.1128/AAC.00156-11.
18. Viveiros M, Dupont M, Rodrigues L, Couto I, Davin-Regli A, Martins M, Pagès J-M, Amaral L. 2007. Antibiotic stress, genetic response and altered permeability of E. coli. PLoS One 2:e365. http://dx.doi.org/10.1371/journal.pone.0000365.
19. Srinivasan VB, Rajamohan G. 2013. KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance. Antimicrob Agents Chemother 57:4449-4462. http://dx.doi.org/10.1128/AAC.02284-12.
20. McMurry LM, Oethinger M, Levy SB. 1998. Triclosan targets lipid synthesis. Nature 394:531-532. http://dx.doi.org/10.1038/28970.
21. Webber MA, Randall LP, Cooles S, Woodward MJ, Piddock LJV. 2008. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 62:83-91. http://dx.doi.org/10.1093/jac/dkn137.
22. Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ, Piddock LJV. 2009. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother 64:973-985. http://dx.doi.org/10.1093/jac/dkp320.
23. Abuzaid A, Hamouda A, Amyes SGB. 2012. Klebsiella pneumoniae susceptibility to biocides and its association with cepA, qacôE and qacE efflux pump genes and antibiotic resistance. J Hosp Infect 81:87-91. http://dx.doi.org/10.1016/j.jhin.2012.03.003.
24. De Majumdar S, Veleba M, Finn S, Fanning S, Schneiders T. 2013. Elucidating the regulon of the multidrug resistance regulator RarA in Klebsiella pneumoniae. Antimicrob Agents Chemother 57:1603-1609. http://dx.doi.org/10.1128/AAC.01998-12.
25. Srinivasan VB, Venkataramaiah M, Mondal A, Vaidyanathan V, Govil T, Rajamohan G. 2012. Functional characterization of a novel outer membrane porin KpnO, regulated by PhoBR two-component system in Klebsiella pneumoniae NTUH-K2044. PLoS One 7:e41505. http://dx.doi.org/10.1371/journal.pone.0041505.
26. Grare M, Dibama HM, Lafosse S, Ribon A, Mourer M, Regnouf-de-Vains J-B, Finance C, Duval RE. 2010. Cationic compounds with activity against multidrug-resistant bacteria: interest of a new compound compared with two older antiseptics, hexamidine and chlorhexidine. Clin Microbiol Infect 16:432-438. http://dx.doi.org/10.1111/j.1469-0691.2009.02837.x.
27. Warnke PH, Lott AJS, Sherry E, Wiltfang J, Podschun R. 2013. The ongoing battle against multi-resistant strains: in-vitro inhibition of hospital-acquired MRSA, VRE, Pseudomonas, ESBL E. coli and Klebsiella species in the presence of plant-derived antiseptic oils. J Craniomaxillofac Surg 41:321-326. http://dx.doi.org/10.1016/j.jcms.2012.10.012.
28. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555-4558. http://dx.doi.org/10.1128/AEM.66.10.4555-4558.2000.
29. Brisse S, Verhoef J. 2001. Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. Int J Syst Evol Microbiol 51(Pt 3):915-924. http://dx.doi.org/10.1099/00207713-51-3-915.
30. Morrisey I, Oggioni MR, Knight D, Curiao T, Coque TM, Kalkanci A, Martinez JL, BIOHYPO Consortium. 2013. Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS One 9:e86669. http://dx.doi.org/10.1371/journal.pone.086669.
31. Martínez JL, Coque TM, Baquero F. 2014. What is a resistance gene? Ranking risk in resistomes. Nat Rev Microbiol 13:116-123. http://dx.doi.org/10.1038/nrmicro3399.
32. Shea A, Wolcott M, Daefler S, Rozak DA. 2012. Biolog phenotype microarrays. Methods Mol Biol 881:331-373. http://dx.doi.org/10.1007/978-1-61779-827-6-12.
33. Foucault M-L, Depardieu F, Courvalin P, Grillot-Courvalin C. 2010. Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci. Proc Natl Acad Sci U S A 107:16964-16969. http://dx.doi.org/10.1073/pnas.1006855107.
34. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(ôdelta delta C(T) ) method. Methods 25:402-408. http://dx.doi.org/10.1006/meth.2001.1262.
35. Sun Y, Dai M, Hao H, Wang Y, Huang L, Almofti YA, Liu Z, Yuan Z. 2011. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium. PLoS One 6:e23471. http://dx.doi.org/10.1371/journal.pone.0023471.
36. McCay PH, Ocampo-Sosa AA, Fleming GTA. 2010. Effect of subinhibitory concentrations of benzalkonium chloride on the competitiveness of Pseudomonas aeruginosa grown in continuous culture. Microbiology 156: 30-38. http://dx.doi.org/10.1099/mic.0.029751-0.
37. Karatzas KAG, Randall LP, Webber M, Piddock LJV, Humphrey TJ, Woodward MJ, Coldham NG. 2008. Phenotypic and proteomic characterization of multiply antibiotic-resistant variants ofSalmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol 74:1508-1516. http://dx.doi.org/10.1128/AEM.01931-07.
38. Moen B, Rudi K, Bore E, Langsrud S. 2012. Subminimal inhibitory concentrations of the disinfectant benzalkonium chloride select for a tolerant subpopulation of Escherichia coli with inheritable characteristics. Int J Mol Sci 13:4101-4123. http://dx.doi.org/10.3390/ijms13044101.
39. Condell O, Iversen C, Cooney S, Power KA, Walsh C, Burgess C, Fanning S. 2012. Efficacy of biocides used in the modern food industry to control Salmonella enterica, and links between biocide tolerance and resistance to clinically relevant antimicrobial compounds. Appl Environ Microbiol 3087-3097. 78:3087-3097. http://dx.doi.org/10.1128/AEM.07534-11.
40. Sanchez P, Moreno E, Martinez JL. 2005. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother 49:781-782. http://dx.doi.org/10.1128/AAC.49.2.781-782.2005.
41. Rensch U, Klein G, Schwarz S, Kaspar H, de Jong A, Kehrenberg C. 2013. Comparative analysis of the susceptibility to triclosan and three other biocides of avian Salmonella enterica isolates collected 1979 through 1994 and 2004 through 2010. J Food Prot 76:653-656. http://dx.doi.org/10.4315/0362-028X.JFP-12-420.
42. Rensch U, Klein G, Kehrenberg C. 2013. Analysis of triclosan-selected Salmonella enterica mutants of eight serovars revealed increased aminoglycoside susceptibility and reduced growth rates. PLoS One 8:e78310. http://dx.doi.org/10.1371/journal.pone.0078310.
43. Pérez A, Poza M, Aranda J, Latasa C, Medrano FJ, Tomás M, Romero A, Lasa I, Bou G. 2012. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob Agents Chemother 56:6256-6266. http://dx.doi.org/10.1128/AAC.01085-12.
44. Yu BJ, Kim JA, Ju HM, Choi S-K, Hwang SJ, Park S, Kim E, Pan J-G. 2012. Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli. J Microbiol 50:785-791. http://dx.doi.org/10.1007/s12275-012-2439-0.
45. Giraud E, Baucheron S, Virlogeux-Payant I, Nishino K, Cloeckaert A. 2013. Effects of natural mutations in the ramRA locus on invasiveness of epidemic fluoroquinolone-resistant Salmonella enterica serovar Typhimurium isolates. J Infect Dis 207:794-802. http://dx.doi.org/10.1093/infdis/jis755.
46. Bratu S, Landman D, George A, Salvani J, Quale J. 2009. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J Antimicrob Chemother 64:278-283. http://dx.doi.org/10.1093/jac/dkp186.
47. Rosenblum R, Khan E, Gonzalez G, Hasan R, Schneiders T. 2011. Genetic regulation of the ramA locus and its expression in clinical isolates of Klebsiella pneumoniae. Int J Antimicrob Agents 38:39-45. http://dx.doi.org/10.1016/j.ijantimicag.2011.02.012.
48. Ruzin A, Visalli MA, Keeney D, Bradford PA. 2005. Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother 49: 1017-1022. http://dx.doi.org/10.1128/AAC.49.3.1017-1022.2005.
49. O'Regan E, Quinn T, Pagès J-M, McCusker M, Piddock L, Fanning S. 2009. Multiple regulatory pathways associated with high-level ciprofloxacin and multidrug resistance in Salmonella enterica serovar Enteritidis: involvement of RamA and other global regulators. Antimicrob Agents Chemother 53:1080-1087. http://dx.doi.org/10.1128/AAC.01005-08.
50. Veleba M, Higgins PG, Gonzalez G, Seifert H, Schneiders T. 2012. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 56:4450-4458. http://dx.doi.org/10.1128/AAC.00456-12.
51. Chollet R, Chevalier J, Bollet C, Pages J-M, Davin-Regli A. 2004. RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob Agents Chemother 48:2518-2523. http://dx.doi.org/10.1128/AAC.48.7.2518-2523.2004.
52. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S. 2009. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J Antimicrob Chemother 64:1175-1180. http://dx.doi.org/10.1093/jac/dkp347.
53. McMurry LM, Oethinger MLS, Levy SB. 1998. Triclosan targets lipid synthesis. Nature 94:531-532.
54. McMurry LM, Oethinger MLS, Levy SB. 1998. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 166:305-309. http://dx.doi.org/10.1111/j.1574-6968.1998.tb13905.x.
55. Padilla E, Llobet E, Domenech-Sanchez A, Martínez-Martínez L, Bengoechea JA, Alberti S. 2010. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54:177-183. http://dx.doi.org/10.1128/AAC.00715-09.
56. Casaz P, Garrity-Ryan LK, McKenney D, Jackson C, Levy SB, Tanaka SK, Alekshun MN. 2006. MarA, SoxS and Rob function as virulence factors in an Escherichia coli murine model of ascending pyelonephritis. Microbiology 152:3643-3650. http://dx.doi.org/10.1099/mic.0.2006/000604-0.
57. Chaudhuri RR, Sebaihia M, Hobman JL, Webber MA, Leyton DL, Goldberg MD, Cunningham AF, Scott-Tucker A, Ferguson PR, Thomas CM, Frankel G, Tang CM, Dudley EG, Roberts IS, Rasko DA, Pallen MJ, Parkhill J, Nataro JP, Thomson NR, Henderson IR. 2010. Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042. PLoS One 5:e8801. http://dx.doi.org/10.1371/journal.pone.0008801.
58. Xue J, Murrieta CM, Rule DC, Miller KW. 2008. Exogenous or L-rhamnose-derived 1,2-propanediol is metabolized via a pduD-dependent pathway in Listeria innocua. Appl Environ Microbiol 74:7073-7079. http://dx.doi.org/10.1128/AEM.01074-08.
59. Norris FA, Wilson MP, Wallis TS, Galyov EE, Majerus PW. 1998. SopB, a protein required for virulence of Salmonella dublin, is an inositol phosphate phosphatase. Proc Natl Acad Sci U S A 95:14057-14059. http://dx.doi.org/10.1073/pnas.95.24.14057.
60. CLSI. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. CLSI, Wayne, PA.